# Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations

> **NCT00665743** · PHASE1 · COMPLETED · sponsor: **POZEN** · enrollment: 30 (estimated)

## Conditions studied

- Arthritis

## Interventions

- **DRUG:** PN400
- **DRUG:** naproxen
- **DRUG:** naproxen

## Key facts

- **NCT ID:** NCT00665743
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2008-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00665743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00665743, "Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00665743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*